View in EDS HTML Full Text PDF Full Text

Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markers.

Saved in:
Bibliographic Details
Title: Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markers.
Authors: Hanf D; Department of Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC) and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Translational Medical Oncology, Faculty of Medicine, Carl Gustav Carus University Hospital, TUD Dresden University of Technology, Dresden, Germany.; Partner Site Dresden, German Cancer Consortium (DKTK), Heidelberg, Germany., Fasching P; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany., Gass P; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany., Matthias W Beckmann; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany., Hack CC; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany., Heindl F; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany., Lothar Häberle; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Biostatistics Unit, Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., John N; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Biostatistics Unit, Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Erber R; Institute of Pathology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany., Press MF; Department of Pathology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA., Rübner M; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany., Pöschke P; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany. patrik.poeschke@uk-erlangen.de.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany. patrik.poeschke@uk-erlangen.de.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany. patrik.poeschke@uk-erlangen.de.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Feb; Vol. 210 (1), pp. 125-134. Date of Electronic Publication: 2024 Nov 26.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39586971
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hanf+D%22">Hanf D</searchLink>; Department of Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC) and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Translational Medical Oncology, Faculty of Medicine, Carl Gustav Carus University Hospital, TUD Dresden University of Technology, Dresden, Germany.; Partner Site Dresden, German Cancer Consortium (DKTK), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Fasching+P%22">Fasching P</searchLink>; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Gass+P%22">Gass P</searchLink>; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Matthias+W+Beckmann%22">Matthias W Beckmann</searchLink>; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Hack+CC%22">Hack CC</searchLink>; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Heindl+F%22">Heindl F</searchLink>; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Lothar+Häberle%22">Lothar Häberle</searchLink>; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Biostatistics Unit, Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22John+N%22">John N</searchLink>; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Biostatistics Unit, Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Erber+R%22">Erber R</searchLink>; Institute of Pathology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Press+MF%22">Press MF</searchLink>; Department of Pathology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rübner+M%22">Rübner M</searchLink>; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Pöschke+P%22">Pöschke P</searchLink>; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN) / Friedrich Alexander University of Erlangen-Nuremberg (FAU), Universitätsstrasse 21-23, 91054, Erlangen, Germany. patrik.poeschke@uk-erlangen.de.; Comprehensive Cancer Center Alliance WERA (CCC), Erlangen, Germany. patrik.poeschke@uk-erlangen.de.; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany. patrik.poeschke@uk-erlangen.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2025 Feb; Vol. 210 (1), pp. 125-134. <i>Date of Electronic Publication: </i>2024 Nov 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39586971
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-024-07545-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 125
    Titles:
      – TitleFull: Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hanf D
      – PersonEntity:
          Name:
            NameFull: Fasching P
      – PersonEntity:
          Name:
            NameFull: Gass P
      – PersonEntity:
          Name:
            NameFull: Matthias W Beckmann
      – PersonEntity:
          Name:
            NameFull: Hack CC
      – PersonEntity:
          Name:
            NameFull: Heindl F
      – PersonEntity:
          Name:
            NameFull: Lothar Häberle
      – PersonEntity:
          Name:
            NameFull: John N
      – PersonEntity:
          Name:
            NameFull: Erber R
      – PersonEntity:
          Name:
            NameFull: Press MF
      – PersonEntity:
          Name:
            NameFull: Rübner M
      – PersonEntity:
          Name:
            NameFull: Pöschke P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 210
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1